1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. Netherlands >
  5. Gilde Healthcare

Gilde Healthcare Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Gilde Healthcare has acquired 5 companies. It has also invested in 1 other.

Gilde Healthcare’s most common sectors for investment arelife science (48%) and medical products (24%) . The Firm’s most common investment types include venture (57%) and buyout (lbo, mbo, mbi) (26%). In total, Gilde Healthcare has invested in 4 US states and 9 different countries.

In the last 3 years, Gilde Healthcare has exited 4 companies. The Firm’s most common exit type is trade sale (48%). Gilde Healthcare’s largest (disclosed) exit occurred in 2014 when it sold Santaris Pharma A/S for $250M.

Join Mergr to view Gilde Healthcare’s full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity89
    • M&A Buy Activity55
    • M&A Sell Activity34
  • Total Sectors Invested 10
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 33
  • M&A Advisors 11

Gilde Healthcare

Gilde Healthcare Partners BV

Stadsplateau 36,
Utrecht, 3521 AZ
Netherlands
31 30 219 25 65
www.gildehealthcare.com
healthcare@gildehealthcare.com

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Information Technology, Life Science, Manufacturing, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Nordic

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 2 15
Investment Size - -
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (2.0/yr) # 45 4 4 2 - - 55
Sell (1.4/yr) # 27 3 1 1 2 - 34
vol $1.6B $231M $1.9B
  89

Most Recent M&A

Company Date Value Type
Lumeon, Inc. 2024-08-08 - Trade Sale
Boston, Massachusetts · www.lumeon.com
RAD-x Management GmbH 2024-03-18 - Secondary Sale
Mannheim, Germany · www.rad-x.eu
Swiss Dental Solutions AG 2023-12-18 - Buyout (LBO, MBO, MBI)
Kreuzlingen, Switzerland · www.swissdentalsolutions.com
Scharenborg Groep 2023-09-15 - Buyout (LBO, MBO, MBI)
Hengelo, Netherlands · www.scharenborggroep.nl
Zetacom B.V. 2023-02-15 - Merger
Zoetermeer, Netherlands · www.zetacom.nl
Essange Reagents BV 2022-08-29 - Divestiture
Amsterdam, Netherlands · www.essange-reagents.com
Chr. Diener GmbH & Co. KG 2022-07-05 - Buyout (LBO, MBO, MBI)
Tuttlingen, Germany · www.diener-gmbh.de
SpliceBio SL 2022-02-16 - Venture
Barcelona, Spain · www.splice.bio
Jecture GmbH 2022-02-10 - Buyout (LBO, MBO, MBI)
Freiensteinau, Germany · www.jecture.com
Acti-Med AG 2022-02-10 - Merger
Freiensteinau, Germany · www.acti-med.de
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Jecture GmbH 2022-02-10 Acti-Med AG 2022-02-10 2
Freiensteinau, Germany · www.jecture.com Freiensteinau, Germany · www.acti-med.de

M&A by Sector

Sector Current # Value All-time # Value
Life Science 10 (48%) - 26 (47%) -
Medical Products 5 (24%) - 13 (24%) -
Healthcare Services 3 (14%) - 6 (11%) -
Information Technology 1 (5%) - 4 (7%) -
Business Services - - 1 (2%) -
Consumer Services - - 1 (2%) -
Food 1 (5%) - 1 (2%) -
Manufacturing 1 (5%) - 1 (2%) -
Staffing - - 1 (2%) -
Test/Measurement Equipment - - 1 (2%) -
Total 21 - 55 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Netherlands 11 (52%) - 21 (38%) -
United States 1 (5%) - 9 (16%) -
  California 1 (5%) - 4 (7%) -
  Massachusetts - - 3 (5%) -
  New Hampshire - - 1 (2%) -
Germany 3 (14%) - 8 (15%) -
United Kingdom 1 (5%) - 4 (7%) -
Denmark 1 (5%) - 4 (7%) -
Switzerland 2 (10%) - 3 (5%) -
Spain 1 (5%) - 3 (5%) -
Belgium - - 2 (4%) -
Ireland 1 (5%) - 1 (2%) -
Total 21 - 55 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 6 (29%) - 31 (56%) -
Buyout (LBO, MBO, MBI) 10 (48%) - 14 (25%) -
Growth Capital 3 (14%) - 7 (13%) -
Secondary Buyout 1 (5%) - 2 (4%) -
Divestiture 1 (5%) - 1 (2%) -
Total 21 - 55 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 13 (38%) 1.7B (92%)
IPO 10 (29%) -
Secondary Sale 5 (15%) -
Trade Sale 4 (12%) 150M (8%)
Merger 2 (6%) -
Total 34 $1.9B

Top M&A Advisors

Financial Deals
William Blair
 1
Lincoln International
 1
PwC Corporate Finance
 1
Legal Deals
Shearman & Sterling
 1
Lupp + Partner
 1
Dentons
 1

Deal Values

sell # Total
$100M to $1B 9 $1.8B
< $100M 1 $80M
TOTAL $1.9B
Largest Santaris Pharma A/S
$250M (2014-08-06)

M&A Connections

Deals
Acquired from
Investor(s)
4%
2 (4%)
Strategic(s)
2%
1 (2%)
Exited to
Investor(s)
15%
5 (15%)
Strategic(s)
53%
18 (53%)

Investor Summary

Investor Type

Private Equity Firm

Size

Large

PE Assets

2.6B EUR

Established

1982

Specialist/Generalist

Specialist

Leadership

Edwin de Graaf

Co-Founder & Managing Partner

Pieter van der Meer

Co-founder & Managing Partner

Arthur Franken

General Partner

Hugo de Bruin

General Partner

Janke Dittmer

General Partner

FAQ

When was Gilde Healthcare founded?

Gilde Healthcare was founded in 1982.

What type of investor is Gilde Healthcare?

Gilde Healthcare is a private equity firm.

Where is Gilde Healthcare headquartered?

Gilde Healthcare is headquartered in Utrecht, Netherlands.

How much capital does Gilde Healthcare have under management?

Gilde Healthcare has 2.6B EUR under management.

 Subscribe to unlock this and 210,171
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 203K M&A Transactions
  • 206K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal